Skip to main content
. 2018 Feb 1;2018(2):CD001269. doi: 10.1002/14651858.CD001269.pub6

10.2. Analysis.

10.2

Comparison 10 Serious adverse events: demyelinating diseases (multiple sclerosis, optic neuritis) ‐ case‐control studies, Outcome 2 Influenza vaccination (seasonal) ‐ general population ‐ multiple sclerosis (adjusted data).